Breast Cancer Information

Are Obese Women Getting Short-Changed By Chemotherapy Treatments?


How much chemotherapy does an obese woman need? Typically an obese woman with breast cancer would receive reduced doses of chemotherapy as they battle breast cancer.

Back in June of 2005, a study published in the Archives of Internal Medicine concluded that obese women should receive chemotherapy based on their actual weight, and not in reduced as amounts as it the standard practice.

And now again a study presented in the August 2005 edition of Lancet claims that doctors should not reduce chemotherapy doses for obese women when no receptors for the hormone oestrogen have been found on the breast cancer cells. This type of cancer is called oestrogen-receptor negative.

Clinicians often reduce chemotherapy doses for obese patients because of worries about how the treatment may react with the patient and affect their overall health.

According to the study's director Marco Colleoni of the European Institute of Oncology, Italy, and his colleagues, reducing the first course of chemotherapy for obese patients with oestrogen-receptor negative breast cancer proves "detrimental".

Colleoni and his team looked at the relation between body-mass index (BMI), chemotherapy dose reduction, oestrogen receptor expression, and outcome for pre-menopausal women with breast cancer by examining data from four randomized trials.

They found that 97 out of 249 obese patients received less than 85% of protocol specified dose during the first course of chemotherapy compared with patients with normal and intermediate BMI.

Obese patients with oestrogen-receptor negative disease that received 85% or more of the first protocol specified dose had significantly better disease-free survival and overall survival than those who received less than 85% of the normally recommended dosage.

Yet, obese patients with oestrogen-receptor positive breast cancer who had reduced doses of chemotherapy did not have a significant difference in their outcome compared with those given the recommended chemotherapy doses.

And contrary to popular practice, the researchers also noticed that obese patients initially treated with protocol doses of chemotherapy did not have more toxicity than patients who received reduced doses.

Dr Marco Colleoni concluded that, "Our findings suggest that for women with ER-absent or ER-low tumours, reduction in chemotherapy dose should be avoided."

The message for obese women coping with cancer is to be aware of your risks and rights. Ask your doctor will she recommend lower doses of chemotherapy for you based on your weight and ask why.

Resources: Lancet, Archives of Internal Medicine

Health author and Stanford University graduate Naweko San-Joyz lovingly writes from her home in San Diego. Her works include Acne Messages: Crack the Code of Your Zits and Say Goodbye to Acne (ISBN: 0974912204) and Skinny Fat Chicks, Why We're Still Not Getting This Dieting Thing (ISBN: 0974912212). Naweko created the Noixia philosophy to help people enhance their lives by connecting with their inner-mysteries and inner-selves. Her works take often over-looked, yet viable research and transforms in into practical tools that people can use to improve their health. Get useful, but too often ignored women's health news by visiting http://www.Noixia.com, Where Beauty Means Health.


MORE RESOURCES:
Google

Enews 2.0

Low Levels of Vitamin D Spell Trouble for Breast Cancer Patients
U.S. News & World Report, DC - 1 hour ago
By Amanda Gardner FRIDAY, May 16 (HealthDay News) -- Women with breast cancer who have a vitamin D deficiency at the time of diagnosis are more likely to ...
Vitamin D deficiency linked to poorer breast cancer outcomes: study The Canadian Press
Breast cancer linked to Vitamin D deficiency Hindu
More Aggressive Breast Cancer Linked to Vitamin D Deficiency ABC News
Los Angeles Times - Globe and Mail
all 216 news articles


Victim of bungled breast cancer tests urges others to get second ...
The Canadian Press, TORONTO - 1 hour ago
TORONTO ? For most women, there are few more terrifying words to hear than: "You have breast cancer." Unless, of course, it's being told the recommended ...


Blood Test Helps Docs Assess Breast Cancer Treatment
U.S. News & World Report, DC - 1 hour ago
In this study, Liu and colleagues measured the number of circulating tumor cells (CTC) in blood samples collected from metastatic breast cancer patients ...


AFP

Vitamin D deficiency linked to breast cancer in new study
AFP - 4 hours ago
WASHINGTON (AFP) ? Women deficient in vitamin D at the time of a breast cancer diagnosis are more likely to die or see the tumor spread, a Canadian study ...


Brocktown News

GlxoSmithKline: Drug combo study shows positive result in treating ...
Forbes, NY - 53 minutes ago
... data from a Phase III trial of the combination of two targeted agents, Tykerb and trastuzumab, in women with HER2-positive metastatic breast cancer. ...
Herceptin enhances Tykerb for breast cancer -study guardian.co.uk
Drug combo helps women with advanced breast cancer The Associated Press
GSK Announces Results of First Phase III Trial Evaluating Tykerb(R ... PR Newswire (press release)
XETV FOX6 San Diego - WBXH
all 159 news articles


ChattahBox

Physical activity may prevent breast cancer
Times of India, India - 8 hours ago
A new study has found that women who engage in physical activity are 25 per cent less likely to develop breast cancer. However, researchers also discovered ...
Link Between Vitamin D Status And Breast Cancer Illuminated Science Daily (press release)
Exercise when young may cut breast cancer Los Angeles Times
Regular Aspirin Intake Cuts Breast Cancer Risk Medi News Direct
Jackson Sun - MedIndia
all 510 news articles


Vitamin D may help curb breast cancer, study finds
The Associated Press - 10 hours ago
Breast cancer patients with low levels of vitamin D were much more likely to die of the disease or have it spread than patients getting enough of the ...


Eisai says drug active in advanced breast cancer
Reuters - 9 hours ago
T: Quote, Profile, Research) said on Friday that its experimental treatment for advanced breast cancer had shown tumour fighting activity in mid-stage ...


Failed lung cancer drug has breast cancer promise
guardian.co.uk, UK - 14 hours ago
Combining Iressa with the breast cancer drug Arimidex helped women survive 45 percent longer without the cancer coming back than using Arimidex alone, ...


TV3 News

Unpublished data shows breast cancer drug 'third less effective'
guardian.co.uk, UK - 15 hours ago
Unpublished data from trials of the breast cancer drug Herceptin show that it may be up to a third less effective than has been claimed, experts will say ...
Herceptin 'may be less effective Telegraph.co.uk
Concerns raised over effectiveness of Herceptin Radio New Zealand
all 6 news articles

Breast-Cancer - Google News

home | site map
© 2006